It also has been reported that the downregulation of H19 could induce oxidative stress and reverse chemotherapy resistance of CD133+ CSCs by blocking the MAPK/ERK signaling pathway in HCC [38]. The gene discussed is H19; the disease is hepatocellular carcinoma.